Skip to main content
Log in

Undiagnosed diabetes has high economic burden in USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. proportion of glycosylated haemoglobin

Reference

  • Dall TM, et al. The Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes, and Prediabetes. Diabetes Care : 2 Apr 2019. Available from: URL: http://doi.org/10.2337/dc18-1226

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Undiagnosed diabetes has high economic burden in USA. PharmacoEcon Outcomes News 826, 32 (2019). https://doi.org/10.1007/s40274-019-5834-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5834-5

Navigation